18P A translational project of the WSG-ADAPT-TN trial demonstrates immunomodulatory and anti-viral defense gene networks predicting pathological complete response (pCR) and survival after de-escalated neoadjuvant chemotherapy (NACT) in early triple-negative breast cancer (eTNBC)

Authors :: M. Graeser
N. Harbeck
O. Gluz
U.A. Nitz
M. Christgen
S. Kuemmel
E-M. Grischke
H. Forstbauer
M. Braun
M. Warm
J.C. Hackmann
C. Uleer
B. Aktas
R. Würstlein
E. Pelz
C. Zu Eulenburg
H. Kreipe
M. Trau
C. Stirzaker
D. Korbie
Source :: ESMO Open. 8:101242
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Full Text Access

Tools